Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India
Indian Heart Journal · 2023
DOI: 10.1016/j.ihj.2023.02.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Heart Journal, 2023. Verfasst von Aravind P Gandhi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Medicine, ESIC Medical College & Hospital, Hyderabad, India. Electronic address: aravindsocialdoc@gmail.com. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Immunization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Vaccines against the COVID-19 pandemic were introduced in late 2020. The present study has been conducted to study the serious Adverse Events Following Immunization (AEFIs) reported for COVID-19 vaccines from India. METHODS: Secondary data analysis of the causality assessment reports for the 1112 serious AEFIs published by the Ministry of Health & Family Welfare, Government of India, was conducted. For the current analysis, all the reports published till 29.03.2022 were included. The primary outcome variables analyzed were the consistent causal association and the thromboembolic events. RESULTS: The majority of the serious AEFIs assessed were either coincidental (578, 52%) or vaccine product related (218, 19.6%). All the serious AEFIs were reported among the Covishield (992, 89.2%) and COVAXIN (120, 10.8%) vaccines. Among these, 401 (36.1%) were deaths, and 711 (63.9%) were hospitalized and recovered. On adjusted analysis, females, the younger age group and non-fatal AEFIs showed a statistically significant consistent causal association with COVID-19 vaccination. Thromboembolic events were reported among 209 (18.8%) of the analyzed participants, with a significant association with higher age and case fatality rate. CONCLUSION: Deaths reported under serious AEFIs were found to have a relatively lower consistent causal relationship with the COVID-19 vaccines than the recovered hospitalizations in India. No consistent causal association was found between the thromboembolic events and the type of COVID-19 vaccine administered in India.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Community Medicine, ESIC Medical College & Hospital, Hyderabad, India. Electronic address: aravindsocialdoc@gmail.com.
- Department of Community Medicine & Family Medicine, All India Institute of Medical Sciences, Gorakhpur, India. Electronic address: venkatesh2007mbbs@gmail.com.
- Department of Pharmacology, PGIMER, Chandigarh, India.
Zitieren
APA
Gandhi, A. P., Venkatesh, U., & Murali, N. (2023). Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2023.02.004
Vancouver
Gandhi AP, Venkatesh U, Murali N. Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India. Indian Heart Journal. 2023. doi:10.1016/j.ihj.2023.02.004
BibTeX
@article{Gandhi2023,
author = {Gandhi, Aravind P and Venkatesh, U and Murali, Naveen},
title = {Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India},
journal = {Indian Heart Journal},
year = {2023},
doi = {10.1016/j.ihj.2023.02.004}
}
EUVIMED